SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-008039
Filing Date
2024-03-15
Accepted
2024-03-15 12:47:37
Documents
40
Period of Report
2024-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ftlf20240315_8k.htm   iXBRL 8-K 24074
2 EXHIBIT 99.1 ex_640108.htm EX-99.1 11856
3 EXHIBIT 99.2 ex_640107.htm EX-99.2 14037
8 a01.jpg GRAPHIC 115785
9 a02.jpg GRAPHIC 170004
10 a03.jpg GRAPHIC 176479
11 a04.jpg GRAPHIC 164523
12 a05.jpg GRAPHIC 130068
13 a06.jpg GRAPHIC 257991
14 a07.jpg GRAPHIC 229326
15 a08.jpg GRAPHIC 163588
16 a09.jpg GRAPHIC 138009
17 a10.jpg GRAPHIC 130252
18 a11.jpg GRAPHIC 196198
19 a12.jpg GRAPHIC 172519
20 a13.jpg GRAPHIC 131205
21 a14.jpg GRAPHIC 130061
22 a15.jpg GRAPHIC 174524
23 a16.jpg GRAPHIC 198433
24 a17.jpg GRAPHIC 221010
25 a18.jpg GRAPHIC 253044
26 a19.jpg GRAPHIC 225597
27 a20.jpg GRAPHIC 116147
28 a21.jpg GRAPHIC 32483
29 a22.jpg GRAPHIC 187903
30 b01.jpg GRAPHIC 10808
  Complete submission text file 0001437749-24-008039.txt   5315229

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ftlf-20240315.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ftlf-20240315_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ftlf-20240315_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ftlf-20240315_pre.xml EX-101.PRE 11584
41 EXTRACTED XBRL INSTANCE DOCUMENT ftlf20240315_8k_htm.xml XML 2819
Mailing Address 5214 S. 136TH STREET OMAHA NE 68137
Business Address 5214 S. 136TH STREET OMAHA NE 68137 402-884-1894
FITLIFE BRANDS, INC. (Filer) CIK: 0001374328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41803 | Film No.: 24753521
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)